Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

The findings, published in The Lancet Respiratory Medicine, could be "game-changing" for millions of people with asthma and COPD around the world, scientists say. Asthma attacks and COPD flare-ups ...

According to findings of a study, published in The Lancet Respiratory Medicine, are results from a phase 2 clinical trial ABRA, led by scientists from King's College London, sponsored by the ...

double-dummy, active placebo-controlled randomised trial, The Lancet Respiratory Medicine (2024). DOI: 10.1016/S2213-2600(24)00299-6 ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Pulmonary arterial hypertension (PAH) affected an estimated 192,000 individuals globally in 2021, disproportionately affecting women and older adults.

At Home Sleep Apnea Testing has released a new guide to the advantages of using the FDA-approved WatchPAT One for home sleep ...